"What we have learned in every region of the world is that with strong leadership, clear and comprehensive strategies, consistent communication, and an engaged, empowered and enabled population, it's never too late", says the WHO director-general.
The EMA accepted BNT162b2 for rolling review on the strength of the preclinical and early clinical data on the vaccine. It would continue to assess data until it had enough to make a final decision, it said.
Trial results must be submitted to the Swiss authority as they become available, it added.
The head of the World Health Organisation has said there is hope for a coronavirus vaccine by the end of the year. The announcement by the European Medicines Agency could speed up the process of approving a successful vaccine in the bloc.
"The start of the rolling review means that the committee has started evaluating the first batch of data on the vaccine, which come from laboratory studies - non-clinical data", the EMA stated.
In normal times, pharma companies would complete their tests and compile all their findings first before submitting them for review.
COVID-19 has now killed more than 1 million people around the world.
Fletcher calls on Man Utd to back Solskjaer in transfer market
For Swart an absurdity: "A substitute - I don't like that at all", he said after the narrow win against Brighton VoetbalPrimeur . However, Solskjaer said the situation has changed and that "there is competition for places now" in his existing squad.
Currently, the WHO-led Covax global vaccine facility has nine experimental vaccines covering 168 countries as it seeks to distribute two billion doses to those who most need them by the end of 2021. While the overall review timeline can not be forecast yet, the process should be shorter than a regular evaluation due to the time gained during the rolling review.
The two leading vaccine candidates use different technology to provoke an immune response with the hope of preventing patients from becoming infected with the novel coronavirus.
Pfizer's vaccine is in late-stage studies in the US, Brazil, South Africa, and Argentina.
The head of the USA government's Operation Warp Speed vaccine development programme said on Tuesday efficacy data on one or two vaccines will be available within the next month or two, and that there should be enough supply to immunize 30 million people during November and December.
He said efficacy data on vaccines being put through final-stage clinical trials by United States pharmaceutical firms Moderna and Pfizer are expected to be available in the next several weeks.
In late September, Regional Director for Europe at the WHO Hans Kluge thanked Russian Federation for "its excellent efforts to create a safe and effective vaccine".